United States Urology Drugs Market Report 2017

February 2017 | 121 pages | ID: U8173049ACEEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Urology Drugs

Revenue, means the sales value of Urology Drugs

This report studies sales (consumption) of Urology Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Astellas
• Endo
• GP Pharm
• Tolmar

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• α (alpha) - blockers
• 5 α-reductase inhibitors

Split by applications, this report focuses on sales, market share and growth rate of Urology Drugs in each application, can be divided into

• Hospital
• Clinic

Contents

United States Urology Drugs Market Report 2017

1 UROLOGY DRUGS OVERVIEW

1.1 Product Overview and Scope of Urology Drugs
1.2 Classification of Urology Drugs
  1.2.1 α (alpha) - blockers
  1.2.2 5 α-reductase inhibitors
1.3 Application of Urology Drugs
  1.3.1 Hospital
  1.3.2 Clinic
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Urology Drugs (2012-2022)
  1.4.1 United States Urology Drugs Sales and Growth Rate (2012-2022)
  1.4.2 United States Urology Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES UROLOGY DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Urology Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Urology Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Urology Drugs Average Price by Manufactures (2015 and 2016)
2.4 Urology Drugs Market Competitive Situation and Trends
  2.4.1 Urology Drugs Market Concentration Rate
  2.4.2 Urology Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES UROLOGY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Urology Drugs Sales and Market Share by States (2012-2017)
3.2 United States Urology Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Urology Drugs Price by States (2012-2017)

4 UNITED STATES UROLOGY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Urology Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Urology Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Urology Drugs Price by Type (2012-2017)
4.4 United States Urology Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES UROLOGY DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Urology Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Urology Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES UROLOGY DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Astellas
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Urology Drugs Product Type, Application and Specification
    6.1.2.1 α (alpha) - blockers
    6.1.2.2 5 α-reductase inhibitors
  6.1.3 Astellas Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Endo
  6.2.2 Urology Drugs Product Type, Application and Specification
    6.2.2.1 α (alpha) - blockers
    6.2.2.2 5 α-reductase inhibitors
  6.2.3 Endo Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GP Pharm
  6.3.2 Urology Drugs Product Type, Application and Specification
    6.3.2.1 α (alpha) - blockers
    6.3.2.2 5 α-reductase inhibitors
  6.3.3 GP Pharm Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Tolmar
  6.4.2 Urology Drugs Product Type, Application and Specification
    6.4.2.1 α (alpha) - blockers
    6.4.2.2 5 α-reductase inhibitors
  6.4.3 Tolmar Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview

7 UROLOGY DRUGS MANUFACTURING COST ANALYSIS

7.1 Urology Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Urology Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Urology Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Urology Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES UROLOGY DRUGS MARKET FORECAST (2017-2022)

11.1 United States Urology Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Urology Drugs Sales Forecast by Type (2017-2022)
11.3 United States Urology Drugs Sales Forecast by Application (2017-2022)
11.4 Urology Drugs Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Urology Drugs
Table Classification of Urology Drugs
Figure United States Sales Market Share of Urology Drugs by Type in 2015
Figure α (alpha) - blockers Picture
Figure 5 α-reductase inhibitors Picture
Table Application of Urology Drugs
Figure United States Sales Market Share of Urology Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure United States Urology Drugs Sales and Growth Rate (2012-2022)
Figure United States Urology Drugs Revenue and Growth Rate (2012-2022)
Table United States Urology Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Urology Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Urology Drugs Sales Share by Manufacturers
Figure 2016 Urology Drugs Sales Share by Manufacturers
Table United States Urology Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Urology Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Urology Drugs Revenue Share by Manufacturers
Table 2016 United States Urology Drugs Revenue Share by Manufacturers
Table United States Market Urology Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Urology Drugs Average Price of Key Manufacturers in 2015
Figure Urology Drugs Market Share of Top 3 Manufacturers
Figure Urology Drugs Market Share of Top 5 Manufacturers
Table United States Urology Drugs Sales by States (2012-2017)
Table United States Urology Drugs Sales Share by States (2012-2017)
Figure United States Urology Drugs Sales Market Share by States in 2015
Table United States Urology Drugs Revenue and Market Share by States (2012-2017)
Table United States Urology Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Urology Drugs by States (2012-2017)
Table United States Urology Drugs Price by States (2012-2017)
Table United States Urology Drugs Sales by Type (2012-2017)
Table United States Urology Drugs Sales Share by Type (2012-2017)
Figure United States Urology Drugs Sales Market Share by Type in 2015
Table United States Urology Drugs Revenue and Market Share by Type (2012-2017)
Table United States Urology Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Urology Drugs by Type (2012-2017)
Table United States Urology Drugs Price by Type (2012-2017)
Figure United States Urology Drugs Sales Growth Rate by Type (2012-2017)
Table United States Urology Drugs Sales by Application (2012-2017)
Table United States Urology Drugs Sales Market Share by Application (2012-2017)
Figure United States Urology Drugs Sales Market Share by Application in 2015
Table United States Urology Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Urology Drugs Sales Growth Rate by Application (2012-2017)
Table Astellas Basic Information List
Table Astellas Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Urology Drugs Sales Market Share (2012-2017)
Table Endo Basic Information List
Table Endo Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Endo Urology Drugs Sales Market Share (2012-2017)
Table GP Pharm Basic Information List
Table GP Pharm Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table GP Pharm Urology Drugs Sales Market Share (2012-2017)
Table Tolmar Basic Information List
Table Tolmar Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Tolmar Urology Drugs Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Urology Drugs
Figure Manufacturing Process Analysis of Urology Drugs
Figure Urology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Urology Drugs Major Manufacturers in 2015
Table Major Buyers of Urology Drugs
Table Distributors/Traders List
Figure United States Urology Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Urology Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Urology Drugs Production Forecast by Type (2017-2022)
Table United States Urology Drugs Consumption Forecast by Application (2017-2022)
Table United States Urology Drugs Sales Forecast by States (2017-2022)
Table United States Urology Drugs Sales Share Forecast by States (2017-2022)